SHARON SURREY BARBARI Insider Trading $MNLO VYNE Therapeutics Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SHARON SURREY BARBARI.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SHARON SURREY BARBARI. SHARON SURREY BARBARI is Chief Financial Officer in INTERMUNE INC ($ITMN) and Director in Oculus Innovative Sciences, Inc. ($OCLS) and EVP, Finance & CFO in CYTOKINETICS INC ($CYTK) and Director in AGILE THERAPEUTICS INC ($AGRX) and Director in Menlo Therapeutics Inc. ($MNLO) and Director in Foamix Pharmaceuticals Ltd. ($FOMX).

SHARON SURREY BARBARI in VYNE Therapeutics Inc.

Trading Symbol: MNLO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SHARON SURREY BARBARI: Director
Holdings: 75,000 shares
Latest Transaction: Aug 21 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of SHARON SURREY BARBARI in VYNE Therapeutics Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGRX, CYTK, FOMX, ITMN, OCLS, MNLO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 21 2020MNLOMenlo Therapeutics ...BARBARI SHARONDirectorOption ExerciseM1.4875,000111,00013,971
Aug 21 2020MNLOMenlo Therapeutics ...BARBARI SHARONDirectorBuyM1.4875,000111,00075,0000 to 75 K
Aug 05 2020MNLOMenlo Therapeutics ...BARBARI SHARONDirectorOption ExerciseA1.7222,50038,70022,500
Mar 23 2020MNLOMenlo Therapeutics ...BARBARI SHARON SURREYDirectorOption ExerciseA2.6745,000120,15045,000
Mar 11 2020MNLOMenlo Therapeutics ...BARBARI SHARON SURREYDirectorOption ExerciseA4.5029,271131,72029,271

Page:   1